| Literature DB >> 33562770 |
Kyosuke Suzuki1, Kohsaku Kawakami2, Masafumi Fukiage3, Michinori Oikawa4, Yohei Nishida5, Maki Matsuda6, Takuya Fujita7.
Abstract
Amorphous solid dispersion (ASD) is one of the most promising formulation technologies for improving the oral absorption of poorly soluble drugs, where the maintenance of supersaturation plays a key role in enhancing the absorption process. However, quantitative prediction of oral absorption from ASDs is still difficult. Supersaturated solutions can cause liquid-liquid phase separation through the spinodal decomposition mechanism, which must be adequately comprehended to understand the oral absorption of drugs quantitatively. In this study, albendazole (ALZ) was formulated into ASDs using three types of polymers, poly(methacrylic acid-co-methyl methacrylate) (Eudragit) L100, Vinylpyrrolidone-vinyl acetate copolymer (PVPVA), and hydroxypropyl methylcellulose acetate succinate (HPMCAS). The oral absorption of ALZ in rats administered as ASD suspensions was not explained by dissolution study but was predicted using liquid-liquid phase separation concentration, which suggested that the absorption of ALZ was solubility-limited. The oral administration study in dogs performed using solid capsules demonstrated the low efficacy of ASDs because the absorption was likely to be limited by dissolution rate, which indicated the importance of designing the final dosage form of the ASDs.Entities:
Keywords: albendazole; amorphous solid dispersions; dissolution study; liquid-liquid phase separation; oral absorption; supersaturation
Year: 2021 PMID: 33562770 PMCID: PMC7914868 DOI: 10.3390/pharmaceutics13020220
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321